Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.
作者信息
Ryan L M, McCarty D J
机构信息
Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.
出版信息
Ann Rheum Dis. 1995 Dec;54(12):939-41. doi: 10.1136/ard.54.12.939.
Abstract
摘要
相似文献
1
Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.了解无机焦磷酸代谢：迈向预防二水焦磷酸钙晶体沉积。
Ann Rheum Dis. 1995 Dec;54(12):939-41. doi: 10.1136/ard.54.12.939.
2
Modulation of chondrocyte production of extracellular inorganic pyrophosphate.软骨细胞产生细胞外无机焦磷酸的调节。
Curr Opin Rheumatol. 2004 May;16(3):268-72. doi: 10.1097/00002281-200405000-00017.
3
Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.软骨钙质沉着症和假性痛风的发病机制。无机焦磷酸盐的代谢及二水焦磷酸钙晶体的产生。
Ann Rheum Dis. 1983 Aug;42 Suppl 1(Suppl 1):27-37. doi: 10.1136/ard.42.suppl_1.27.
4
Calcium pyrophosphate dihydrate crystal deposition disease: sonographic findings.二水焦磷酸钙晶体沉积病：超声检查结果
Clin Rheumatol. 2009 Mar;28(3):271-6. doi: 10.1007/s10067-008-1034-6. Epub 2008 Nov 13.
5
Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families.英国家族性焦磷酸钙二水合物晶体沉积所致的家族性软骨钙质沉着症
Br J Rheumatol. 1991 Feb;30(1):10-5. doi: 10.1093/rheumatology/30.1.10.
6
Decrease in crystal growth inhibition rate in the synovial fluid of patients with pseudogout.假性痛风患者滑液中晶体生长抑制率降低。
Ryumachi. 1983 Aug;23(4):202-5.
7
Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.焦磷酸钙晶体沉积病及其他晶体沉积病
Curr Opin Rheumatol. 1992 Aug;4(4):574-82.
8
Crystal deposition diseases: out of sight, out of mind.
Curr Opin Rheumatol. 2005 May;17(3):312-3. doi: 10.1097/01.bor.0000159709.89846.bc.
9
Subcutaneous crystal deposition in pseudogout.假痛风中的皮下晶体沉积。
JAMA. 1980 Nov 7;244(18):2079-80.
10
[Pathogenesis of articular chondrocalcinosis].[关节软骨钙质沉着症的发病机制]
Rev Rhum Mal Osteoartic. 1986 Apr;53(4):277-82.
引用本文的文献
1
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?焦磷酸钙晶体的形成和沉积：我们目前处于什么位置，未来又将如何？
Curr Rheumatol Rep. 2024 Oct;26(10):354-365. doi: 10.1007/s11926-024-01161-w. Epub 2024 Aug 1.
2
Management of temporomandibular joint diseases: a rare case report of coexisting calcium pyrophosphate crystal deposition and synovial chondromatosis.颞下颌关节疾病的治疗：共存焦磷酸钙晶体沉积和滑膜软骨瘤病的罕见病例报告。
BMC Oral Health. 2022 Dec 31;22(1):662. doi: 10.1186/s12903-022-02695-0.
3
Systematic Overview of Solid Particles and Their Host Responses.固体颗粒及其宿主反应的系统综述。
Front Immunol. 2018 May 28;9:1157. doi: 10.3389/fimmu.2018.01157. eCollection 2018.
4
Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.无机焦磷酸酶（PPA1）是人类胃癌的一种负性预后标志物。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12482-90. eCollection 2015.
5
Pathophysiology of articular chondrocalcinosis--role of ANKH.关节软骨钙质沉着症的病理生理学——ANKH 的作用。
Nat Rev Rheumatol. 2011 Feb;7(2):96-104. doi: 10.1038/nrrheum.2010.182. Epub 2010 Nov 23.
6
Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.磷酸钙和焦磷酸钙对基质金属蛋白酶与纤维蛋白结合的不同作用：与炎症关节液中的一种纤维蛋白结合蛋白酶的比较
Clin Exp Immunol. 2004 Apr;136(1):176-87. doi: 10.1111/j.1365-2249.2004.02413.x.
7
Crystal deposition and osteoarthritis.晶体沉积与骨关节炎
Curr Rheumatol Rep. 1999 Dec;1(2):107-11. doi: 10.1007/s11926-999-0006-4.
8
Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.焦磷酸盐和双膦酸盐可抑制无定形磷酸钙介导的基质金属蛋白酶-9与纤维蛋白的结合。
Inflammation. 1999 Aug;23(4):333-60. doi: 10.1023/a:1020209616428.
本文引用的文献
1
The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals.磷酸钙晶体在关节炎患者滑液中的意义：“假痛风综合征”。II. 晶体的鉴定
Ann Intern Med. 1962 May;56:738-45. doi: 10.7326/0003-4819-56-5-738.
2
Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage.胰岛素样生长因子-1通过抑制转化生长因子β1刺激的软骨细胞和软骨产生焦磷酸盐。
Osteoarthritis Cartilage. 1994 Sep;2(3):149-54. doi: 10.1016/s1063-4584(05)80065-2.
3
Gout without hyperuricemia.无高尿酸血症的痛风
JAMA. 1994 Jan 26;271(4):302-3.
4
Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.小鼠浆细胞核苷酸焦磷酸水解酶PC-1的表达在人类肝脏、骨骼和软骨细胞中也有体现。转化生长因子-β对骨肉瘤细胞中PC-1表达的调控。
J Clin Invest. 1994 Aug;94(2):560-7. doi: 10.1172/JCI117370.
5
A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles.一种与猪软骨细胞衍生囊泡相关的独特胞外核苷酸焦磷酸水解酶。
J Clin Invest. 1995 Feb;95(2):699-704. doi: 10.1172/JCI117716.
6
Calcium pyrophosphate dihydrate crystal deposition disease: a review of the literature and a light and electron microscopic study of a case of the temporomandibular joint with numerous intracellular crystals in the chondrocytes.二水焦磷酸钙晶体沉积病：文献综述及颞下颌关节一例的光镜与电镜研究，该病例软骨细胞内有大量晶体
Osteoarthritis Cartilage. 1995 Mar;3(1):35-45. doi: 10.1016/s1063-4584(05)80036-6.
7
A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues.转化生长因子β1对不同关节组织焦磷酸盐生成影响的比较。
Arthritis Rheum. 1993 Apr;36(4):539-42. doi: 10.1002/art.1780360415.
8
Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes.丙磺舒抑制软骨细胞中转化生长因子-β1诱导的焦磷酸盐生成。
J Rheumatol. 1994 May;21(5):896-900.
9
Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture.正常哺乳动物关节透明软骨和纤维软骨在器官培养中焦磷酸盐的释放。
Arthritis Rheum. 1981 Dec;24(12):1522-7. doi: 10.1002/art.1780241211.
10
Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ecto-enzyme.
Arthritis Rheum. 1984 Apr;27(4):404-9. doi: 10.1002/art.1780270407.
Zotero 插件